“Are there differences in the treatment strategies and outcomes between high-risk multiple myeloma patients and those with low-risk disease and without comorbities?” (2009) Hematology Meeting Reports (formerly Haematologica Reports), 2(7). doi:10.4081/hmr.v2i7.407.